Toxnet Award Presented to Mirko Filippetti

During the symposium at ISPRM 2026, Toxnet introduced its inaugural award, recognising contributions to education and collaboration in spasticity management.

The first award was presented to Miko Filippetti in recognition of his strong and consistent contribution across clinical practice, research and education.

Selected following review by multiple experts, Mirko was the top-ranked candidate, with consistently high scores across key areas including clinical practice, research and publications, and education and mentorship. His work reflects extensive experience in managing complex spasticity patients and a comprehensive, multimodal approach to care. He is also recognised for his broader impact within the field and his leadership within the clinical community.

The award was presented by Gerard Francisco and Thierry Deltombe, co-chairs of Toxnet, in honour of Susanna Moraleda, who passed away in 2022. The award recognises her lasting contribution to the Toxnet initiative and her role as a valued colleague within the network, helping to foster a collaborative and educational approach in the field.

The introduction of the Toxnet Award reflects the importance of recognising both individual contributions and the shared commitment that underpins progress in spasticity management.

© 2026 ToxNet. All Rights Reserved.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of unique spasticity patient encounters per month (by the individual)
  • Description of spasticity clinical team & management activities and (numbers, specialities etc)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management (involvement)
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of posters/presentations at local and national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.